Page last updated: 2024-10-30

ketotifen and Facial Pain

ketotifen has been researched along with Facial Pain in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Troeltzsch, M2
Berndt, R1
Woodlock, T1
Messlinger, K1

Other Studies

1 other study available for ketotifen and Facial Pain

ArticleYear
Cutaneous mastocytosis as a rare differential diagnosis for unilateral chronic facial pain and erythema: a case report.
    Journal of orofacial pain, 2013,Fall, Volume: 27, Issue:4

    Topics: Aged; Chronic Pain; Erythema; Facial Pain; Female; Histamine H1 Antagonists; Humans; Ketotifen; Mast

2013